Health and Fitness Health and Fitness
Wed, July 25, 2012
Tue, July 24, 2012
[ Tue, Jul 24th 2012 ] - Market Wire
Neogen reports year end results
Mon, July 23, 2012
Sun, July 22, 2012
Sat, July 21, 2012
Fri, July 20, 2012
Thu, July 19, 2012
Wed, July 18, 2012
Tue, July 17, 2012
Mon, July 16, 2012
[ Mon, Jul 16th 2012 ] - Market Wire
30 a.m. ET
Fri, July 13, 2012
Thu, July 12, 2012
Wed, July 11, 2012
Tue, July 10, 2012
Mon, July 9, 2012
Fri, July 6, 2012
Thu, July 5, 2012
Wed, July 4, 2012
[ Wed, Jul 04th 2012 ] - Market Wire
Warnex Announces Refinancing
Tue, July 3, 2012
Mon, July 2, 2012
Sun, July 1, 2012
Fri, June 29, 2012
Thu, June 28, 2012

Threshold Pharmaceuticals Announces Presentation and Webcast at JMP Securities Healthcare Conference


//health-fitness.news-articles.net/content/2012/ .. ast-at-jmp-securities-healthcare-conference.html
Published in Health and Fitness on Wednesday, July 11th 2012 at 4:38 GMT by Market Wire   Print publication without navigation


July 11, 2012 07:30 ET

Threshold Pharmaceuticals Announces Presentation and Webcast at JMP Securities Healthcare Conference

SOUTH SAN FRANCISCO, CA--(Marketwire - Jul 11, 2012) - Threshold Pharmaceuticals, Inc. (NASDAQ: [ THLD ]) today announced that Dr. Charles Hart, Vice President of Biology at Threshold, is scheduled to present at the JMP Securities Healthcare Conference on Friday, July 13, at 10:30 am Eastern time in New York City.

A live webcast of the presentation will be available under Webcasts in the Investors section of [ www.thresholdpharm.com ]. A replay of the presentation will be archived on the site for 30 days.

About Threshold Pharmaceuticals
Threshold is a biotechnology company focused on the discovery and development of drugs targeting tumor hypoxia, the low oxygen condition found in microenvironments of most solid tumors as well as the bone marrows of some hematologic malignancies. This approach offers broad potential to treat a variety of cancers. By selectively targeting tumor cells, Threshold is building a pipeline of drugs that hold promise to be more effective and less toxic to healthy tissues than conventional anticancer drugs. For additional information, please visit [ www.thresholdpharm.com ].



Publication Contributing Sources